Join
Live feed
·
PRReleasevia Quantisnow
AstraZeneca PLC logo
Blueprint Medicines Corporation logo

Blueprint Medicines Announces BLU-945 Proof-of-Concept Data Supporting Initiation of Comprehensive Combination Development Strategy in EGFR-mutant Non-Small Cell Lung Cancer

ByQuantisnow·Wall Street's wire, on your screen.
AZN· AstraZeneca PLCBPMC· Blueprint Medicines Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AZN (AstraZeneca PLC), BPMC (Blueprint Medicines Corporation) and more on Quantisnow.